BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1135 related articles for article (PubMed ID: 17267743)

  • 1. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.
    Inaba M; Okuno S; Kumeda Y; Yamada S; Imanishi Y; Tabata T; Okamura M; Okada S; Yamakawa T; Ishimura E; Nishizawa Y;
    J Am Soc Nephrol; 2007 Mar; 18(3):896-903. PubMed ID: 17267743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycated albumin versus glycated hemoglobin as glycemic indicator in hemodialysis patients with diabetes mellitus: variables that influence.
    Sany D; Elshahawy Y; Anwar W
    Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):260-73. PubMed ID: 23538348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of glycated albumin, but not glycated hemoglobin, with peripheral vascular calcification in hemodialysis patients with type 2 diabetes.
    Yamada S; Inaba M; Shidara K; Okada S; Emoto M; Ishimura E; Nishizawa Y
    Life Sci; 2008 Sep; 83(13-14):516-9. PubMed ID: 18760286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of glycated albumin, but not glycated hemoglobin, with calcaneus quantitative ultrasound in male hemodialysis patients with type 2 diabetes mellitus.
    Yamada S; Inaba M; Okada S; Imanishi Y; Mori K; Emoto M; Ishimura E; Nishizawa Y
    Metabolism; 2010 Mar; 59(3):390-4. PubMed ID: 19800642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of glycated albumin and hemoglobin A1c concentrations in diabetic subjects on peritoneal and hemodialysis.
    Freedman BI; Shenoy RN; Planer JA; Clay KD; Shihabi ZK; Burkart JM; Cardona CY; Andries L; Peacock TP; Sabio H; Byers JR; Russell GB; Bleyer AJ
    Perit Dial Int; 2010; 30(1):72-9. PubMed ID: 20056983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycated albumin may be a possible alternative to hemoglobin A1c in diabetic patients with anemia.
    Kim S; Min WK; Chun S; Lee W; Park HI
    Clin Chem Lab Med; 2011 Oct; 49(10):1743-7. PubMed ID: 21679130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycated Albumin versus Glycated Hemoglobin as a Glycemic Indicator in Diabetic Patients on Peritoneal Dialysis.
    Kobayashi H; Abe M; Yoshida Y; Suzuki H; Maruyama N; Okada K
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27120597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships of serum haptoglobin concentration with HbA1c and glycated albumin concentrations in Japanese type 2 diabetic patients.
    Suzuki K; Yagi K; Oka R; Saiki Y; Kubota M; Sugihara M; Ito N; Kawashiri MA; Nohara A; Horita H; Takeda Y; Yamagishi M; Kobayashi J
    Clin Chem Lab Med; 2009; 47(1):70-4. PubMed ID: 19072031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma.
    Paroni R; Ceriotti F; Galanello R; Battista Leoni G; Panico A; Scurati E; Paleari R; Chemello L; Quaino V; Scaldaferri L; Lapolla A; Mosca A
    Clin Biochem; 2007 Dec; 40(18):1398-405. PubMed ID: 17919531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of glycated albumin as an indicator of glycemic control status in patients with hemolytic anemia.
    Koga M; Hashimoto K; Murai J; Saito H; Mukai M; Ikegame K; Ogawa H; Kasayama S
    Clin Chim Acta; 2011 Jan; 412(3-4):253-7. PubMed ID: 20965159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum albumin-adjusted glycated albumin as a better indicator of glycemic control in Type 2 diabetes mellitus patients with short duration of hemodialysis.
    Yajima T; Yajima K; Hayashi M; Takahashi H; Yasuda K
    Diabetes Res Clin Pract; 2017 Aug; 130():148-153. PubMed ID: 28641154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycated albumin as an improved indicator of glycemic control in hemodialysis patients with type 2 diabetes based on fasting plasma glucose and oral glucose tolerance test.
    Nagayama H; Inaba M; Okabe R; Emoto M; Ishimura E; Okazaki S; Nishizawa Y
    Biomed Pharmacother; 2009 Mar; 63(3):236-40. PubMed ID: 18538530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct biomarker roles for HbA
    Hayashi A; Takano K; Masaki T; Yoshino S; Ogawa A; Shichiri M
    J Diabetes Complications; 2016; 30(8):1494-1499. PubMed ID: 27614726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment.
    Konya J; Ng JM; Cox H; Cooke M; Lewis N; Bhandari S; Atkin SL; Kilpatrick ES
    Diabet Med; 2013 Oct; 30(10):1250-4. PubMed ID: 23758176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant correlation of glycated albumin, but not glycated haemoglobin, with arterial stiffening in haemodialysis patients with type 2 diabetes.
    Kumeda Y; Inaba M; Shoji S; Ishimura E; Inariba H; Yabe S; Okamura M; Nishizawa Y
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):556-61. PubMed ID: 18248645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum albumin-adjusted glycated albumin reflects glycemic excursion in diabetic patients with severe chronic kidney disease not treated with dialysis.
    Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M
    J Diabetes Complications; 2015; 29(7):913-7. PubMed ID: 26164356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body mass index negatively influences glycated albumin, but not glycated hemoglobin, in diabetic patients.
    Koga M; Matsumoto S; Saito H; Kasayama S
    Endocr J; 2006 Jun; 53(3):387-91. PubMed ID: 16717395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis.
    Peacock TP; Shihabi ZK; Bleyer AJ; Dolbare EL; Byers JR; Knovich MA; Calles-Escandon J; Russell GB; Freedman BI
    Kidney Int; 2008 May; 73(9):1062-8. PubMed ID: 18288102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Target for glycemic control in type 2 diabetic patients on hemodialysis: effects of anemia and erythropoietin injection on hemoglobin A(1c).
    Uzu T; Hatta T; Deji N; Izumiya T; Ueda H; Miyazawa I; Kanasaki M; Isshiki K; Nishio T; Arimura T
    Ther Apher Dial; 2009 Apr; 13(2):89-94. PubMed ID: 19379146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients.
    Freedman BI; Andries L; Shihabi ZK; Rocco MV; Byers JR; Cardona CY; Pickard MA; Henderson DL; Sadler MV; Courchene LM; Jordan JR; Balderston SS; Graham AD; Mauck VL; Russell GB; Bleyer AJ
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1635-43. PubMed ID: 21597024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.